Patents by Inventor Masahiro Fuwa

Masahiro Fuwa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OMIDENEPAG COMBINATION
    Publication number: 20210106569
    Abstract: Described is a combination of a prophylactic or therapeutic agent for glaucoma or ocular hypertension, which is useful as a prophylactic or therapeutic agent for glaucoma or ocular hypertension. By combining omidenepag and ripasudil or netarsudil, each complement and/or enhances the intraocular pressure lowering effect. As the form of administration, they may be administered concomitantly or may be administered as a combination drug.
    Type: Application
    Filed: December 20, 2018
    Publication date: April 15, 2021
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Masahiro FUWA, Takazumi TANIGUCHI
  • Comprehensive Glaucoma Determination Method Utilizing Glaucoma Diagnosis Chip And Deformed Proteomics Cluster Analysis
    Publication number: 20130275349
    Abstract: Provided is a technique for determining a physiological attribute in a mammal, including the onset or progression of human glaucoma, with high accuracy. The results of the determination of genotype date and the results of the determination of cytokine date are consolidated by a consolidated determination unit (114); comparison is made for determining as to which is larger, the number of Case determination procedures or the number of control determination procedures (S330); and it is determined as Case (glaucoma) when the number of Case determination procedures is larger and it is determined as Control (normal person) when the number of Control determination procedures is larger.
    Type: Application
    Filed: December 28, 2011
    Publication date: October 17, 2013
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Kei Tashiro, Shigeru Kinoshita, Tomohito Yagi, Masakazu Nakano, Kazuhiko Mori, Yoko Ikeda, Morio Ueno, Yuichi Tokuda, Katsumi Yagi, Kengo Yoshii, Masahiro Fuwa
  • 4-amino 5-cyanopyrimidine derivatives
    Patent number: 7989446
    Abstract: The present invention provides 4-amino-5-cyanopyrimidine derivatives of the formula: wherein R1, R2 and R3 are defined herein, or pharmaceutically acceptable salts thereof, having a safe and potent adenosine A2a receptor agonistic activity; and also provides an adenosine A2a receptor agonist, an intraocular pressure reducing agent, or a medicine for treating glaucoma, etc., which comprises the compound as an active ingredient.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: August 2, 2011
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Masaya Kato, Norifumi Sato, Minoru Okada, Tetsuyuki Uno, Nobuaki Ito, Yasuhiro Takeji, Hisashi Shinohara, Masahiro Fuwa
  • 4-Amino-5-cyanopyrimidine derivatives
    Publication number: 20110009620
    Abstract: The present invention provides 4-amino-5-cyanopyrimidine derivatives of the formula: wherein R1, R2 and R3 are defined herein, or pharmaceutically acceptable salts thereof, having a safe and potent adenosine A2a receptor agonistic activity; and also provides an adenosine A2a receptor agonist, an intraocular pressure reducing agent, or a medicine for treating glaucoma, etc., which comprises the compound as an active ingredient.
    Type: Application
    Filed: September 22, 2010
    Publication date: January 13, 2011
    Inventors: Masaya Kato, Norifumi Sato, Minoru Okada, Tetsuyuki Uno, Nobuaki Ito, Yasuhiro Takeji, Hisashi Shinohara, Masahiro Fuwa
  • 4-amino-5-cyanopyrimidine derivatives
    Patent number: 7834002
    Abstract: The present invention provides 4-amino-5-cyanopyrimidine derivatives of the formula: wherein R1, R2 and R3 are defined herein, or pharmaceutically acceptable salts thereof, having a safe and potent adenosine A2a receptor agonistic activity; and also provides an adenosine A2a receptor agonist, an intraocular pressure reducing agent, or a medicine for treating glaucoma, etc., which comprises the compound as an active ingredient.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: November 16, 2010
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Masaya Kato, Norifumi Sato, Minoru Okada, Tetsuyuki Uno, Nobuaki Ito, Yasuhiro Takeji, Hisashi Shinohara, Masahiro Fuwa
  • 4-Amino-5-Cyanopyrimidine Derivatives
    Publication number: 20080182854
    Abstract: The present invention provides 4-amino-5-cyanopyrimidine derivatives of the formula: wherein R1, R2 and R3 are defined herein, or pharmaceutically acceptable salts thereof, having a safe and potent adenosine A2a receptor agonistic activity; and also provides an adenosine A2a receptor agonist, an intraocular pressure reducing agent, or a medicine for treating glaucoma, etc., which comprises the compound as an active ingredient.
    Type: Application
    Filed: April 28, 2005
    Publication date: July 31, 2008
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Masaya Kato, Norifumi Sato, Minoru Okada, Tetsuyuki Uno, Nobuaki Ito, Yasuhiro Takeji, Hisashi Shinohara, Masahiro Fuwa